Predictive Oncology Inc. (POAI) earnings
POAI earnings moved a median of -5.78% by the close. Quarterly and annual POAI reports and results, each read against the price at its own news timestamp. Back to the POAI overview →
19 measured POAI earnings events.
Where these POAI earnings landedvs 19 measured POAI earnings reactions
| Middle 50% of POAI earnings reactions | -7.27% to -2.00% |
|---|---|
| Median reaction (to close) | -5.78% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 POAI earnings events with a measured close landed between -7.27% and -2.00%; 11% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Predictive Oncology Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.30% | -8.43% | |
| Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy | Press release | +0.30% | -8.43% | |
| Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | -5.94% | -4.40% | |
| Form 10-Q Predictive Oncology Inc. For: Jun 30 | SEC filing · Form 10-Q | -5.94% | -4.40% | |
| Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | -2.58% | +1.85% | |
| Form 10-Q Predictive Oncology Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.58% | +1.85% | |
| Form 10-K Predictive Oncology Inc. For: Dec 31 | SEC filing · Form 10-K | +1.35% | +0.00% | |
| Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update | Press release | -2.94% | -1.22% | |
| Form 10-Q Predictive Oncology Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.94% | -1.22% | |
| Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +1.61% | -7.68% | |
| Form 10-Q Predictive Oncology Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.61% | -7.68% | |
| Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 | Press release | +2.00% | -6.12% | |
| Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -3.50% | -6.45% | |
| Form 10-Q Predictive Oncology Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.50% | -6.45% | |
| Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024 | Press release | -1.14% | -6.86% | |
| Form 10-K Predictive Oncology Inc. For: Dec 31 | SEC filing · Form 10-K | -0.52% | -13.36% | |
| Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | -5.17% | -5.78% | |
| Form 10-Q Predictive Oncology Inc. For: Sep 30 | SEC filing · Form 10-Q | -5.17% | -5.78% | |
| Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023 | Press release | +0.00% | -2.78% |
Keep exploring
More POAI: analyst actions → · SEC filings → · POAI overview →